Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-08-07

EMA Authorised: Spedra (avanafil) — Phoenix Labs Unlimited Company

View source ↗

Summary

The EMA Authorised Spedra (avanafil) for erectile dysfunction, listing Phoenix Labs Unlimited Company as the MAH with an authorised status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spedra (avanafil)

Snippet

Status: Authorised. Therapeutic area: Erectile Dysfunction. MAH: Phoenix Labs Unlimited Company. Decision date: 05/08/2026